Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Current Drug Targets|April 29, 2005
The ErbB receptors and their ligands in cancer: an overviewN Normanno, C Bianco, L Strizzi, et al.
Breast Cancer Research and Treatment|September 1, 1995
Phase II study of high-dose epirubicin, lonidamine, alpha 2b interferon in advanced breast cancerR V Iaffaioli, A Tortoriello, G Facchini, et al.
The International Journal of Biological Markers|January 1, 1991
Impact of preoperative CA 15-3 levels in operable breast cancer. Comparison with tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA)R V Iaffaioli, F Caponigro, G Esposito, et al.
Journal of Experimental Therapeutics & Oncology|July 1, 1996
Modulation of chemosensitivity by alpha interferon in multiple myeloma and non-Hodgkin's lymphomaR V Iaffaioli, G Facchini, A Tortoriello, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancerC Dittrich, B Coudert, L Paz-Ares, et al.
Breast Cancer Research and Treatment|March 11, 1998
Phase I/II study of paclitaxel and vinorelbine in metastatic breast cancerA Tortoriello, G Facchini, F Caponigro, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 12, 2018
Translational Research: A Future Strategy for Managing Squamous Cell Carcinoma of the Head and Neck?F Caponigro, F Ionna, G Della Vittoria Scarpati, et al.
Pageof 5